KMT2A and acute myeloid leukemia: Furthermore, data from scRNA-Seq conducted on PD BMA sample of AML with MLL1-r and FLT3-TKD confirm that treatment with MI repressed cell events and MLL-FP target genes in CMP cell-clusters.